Perfluorocarbons in the Twenty-First Century: Clinical Applications as Transfusion Alternatives

References

• Ohyanagi H., Saitoh Y. Development and clinical application of perfluorochemical artificial blood. Int J Artif Organs 1986; 9(5)363–8
   PubMed Web of Science ®Google Scholar
• Tremper K. K., Friedman A. E., Levine E. M., et al. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid. Fluosol-DA. N Engl J Med 1982; 307: 277
   PubMed Web of Science ®Google Scholar
• Waxman K., Tremper K. K., Cullen B. F., et al. Perfluorocarbon Infusion in Bleeding Patients Refusing Blood Transfusions. Arch Surg 1984; 119: 721–4
   PubMed Web of Science ®Google Scholar
• Karn K. E., Ogburn P. L., Jr, Julian T., et al. Use of a Whole Blood Substitute, Fluosol-DA 20%, after Massive Postpartum Hemorrhage. Obst Gyn, 65(1): 127–30
   Google Scholar
• Gould S. A., Rosen A. L., Sehgal L. R., et al. Fluosol-DA as a red cell substitute in acute anemia. N Engl J Med 1986; 314: 1653–56
   PubMed Web of Science ®Google Scholar
• Spence R. K. [letter]. Fluosol-DA as a red cell substitute in acute anemia. N Engl J Med 1987; 315: 1677
   Google Scholar
• Reiss J. G. Fluorocarbon-based in vivo oxygen transport and delivery systems. Vox Sang 1991; 61(4)225–39
   PubMedGoogle Scholar
• Spence R. K., McCoy S., Costabile J., et al. Fluosol DA-20 in the treatment of severe anemia: randomized controlled study of 46 patients. Crit Care Med 1990; 18(11)1227–30
   PubMed Web of Science ®Google Scholar
• Zuck T. F., Reiss J. G. Current Status of Injectable Oxygen Carriers. CRC Press, (in press)
   Google Scholar
• Ingram D. A., Forman M. B., Murray J. J. Phagocytic activation of human neutrophils by the detergent component of Fluosol. Am J Pathol 1992; 140(5)1081–7
   PubMedGoogle Scholar
• Kent K. M., Cleman M. W., Cowley M. J., et al. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. A J Cardiol 1990; 66(3)279–84
   PubMed Web of Science ®Google Scholar
• Reiss J. G. Overview of Progress in the Fluorocarbon Approach to in vivo Oxygen Delivery. Blood Substitutes and Oxygen Carriers, T. M. Chang, M. Dekker, New York 1993; 24–43
   Google Scholar
• Goodin T. H., Grossbard E. B., Kaufman R. J., et al. A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study. Crit Care Med 1994; 22: 680–9
   PubMed Web of Science ®Google Scholar
• Thoolen M. J. M. C., Rasbach D. E., Shaw J. H., et al. Preservation of regional and global left ventricular function by intracoronary infusion with oxygenated fluorocarbon emulsion Therox™ in dogs. Biomat. Art. Cells & Immob. Biotech. 1993; 21(1)53–62
   PubMed Web of Science ®Google Scholar
• Meinert H., Fackler R., Knoblich A., et al. On the perfluorocarbon emulsions of second generation. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)95–113
   PubMedGoogle Scholar
• Reiss J. G., Le Blanc M. Preparation of perfluorochemical emulsions for biomedical use: principles, materials and methods. Blood Substitutes: Preparation, Physiology and Medical Applications, K. C. Lowe. Ellis Horwood Ltd, Chichester 1988; 94
   Google Scholar
• Reiss J. G. The design and development of improved fluorocarbon-based products for use in medicine and biology. Art Cells, Blood Subs, and Immob Biotech 1994; 22(2)215–34
   PubMedGoogle Scholar
• Bentley P. K., Johnson O. L., Washington C., et al. Lymphoid tissue responses to concentrated perfluorochemical emulsions in rats. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)1033–6
   PubMed Web of Science ®Google Scholar
• Lowe K. C., Bentley P. K. Retention of perfluorochemicals in rat liver and spleen. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)1029–31
   PubMed Web of Science ®Google Scholar
• Woodle M. C., Lasic D. D. Sterically Stabilized Liposomes. Biochim Biophys Acta 1992; 1113: 171–99
   PubMed Web of Science ®Google Scholar
• Flaim S. F., Hazard D. R., Hogan J., et al. Characterization and mechanism of side-effects of Oxygent™ HT (Highly concentrated fluorocarbon emulsion) in swine. Biomat. Art Cells and Immob Biotech 1991; 19: 383–5
   Google Scholar
• Bruneton J. N., Falewee M. N., Francois E., et al. Preliminary clinical resluts using perfluoroctylbromide (PFOB) for CT imaging of the liver, spleen and vessels. Radiology 1989; 170: 179–83
   PubMed Web of Science ®Google Scholar
• Smith D. J., Lane T. A. Effect of a high concentration perfluorocarbon emulsion on platelet function. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)1045–9
   PubMed Web of Science ®Google Scholar
• Clark L. C., Hoffmann R. E., Davis S. L. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)1085–99
   PubMed Web of Science ®Google Scholar
• Adrianov N. V., Achakov A. I., Zigler M. Induction of cytochrome P-450 by perfluorodecalin in mouse liver microsomes. Bull Exp Biol Med (USSR) 1989; 108: 164–6
   Google Scholar
• Lowe K. C., Armstrong F. H. Biocompatibility studies with perfluorochemical oxygen carriers. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)993–9
   PubMed Web of Science ®Google Scholar
• Armstrong F. H., Lowe K. C. Effects of emulsified perfluorochemicals on liver cytochromes P-450 in rats. Compar Biochem Physiol 1989; 94C: 345–9
   Google Scholar
• Shah I. G., Parsons D. L. Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute. J Pharm Pharmacol 1991; 43(11)790–3
   PubMedGoogle Scholar
• Hoke J. F., Ravis W. R. Effect of a perfluorochemical erythrocyte substitute on the in vitro metabolism of lidocaine using rat liver slices. Res Commun Chem Pathol Pharmacol 1991; 73(3)333–53
   PubMedGoogle Scholar
• Zarif L., Reiss J. G., Pucci B., et al. Biocompatibility of alkyl and perfluoralkyl surfactants derived from THAM. Biomater Artif Cells Immobilization Biotechnol 1993; 21(5)597–608
   PubMed Web of Science ®Google Scholar
• Pelura T. J., Johnson C. S., Tarara T. E., et al. Stabilization of perflubron emulsions with egg yolk phospholipid. Biomater Artif Cells Immobilization Biotechnol 1992; 20(2–4)845–8
   PubMed Web of Science ®Google Scholar
• Cain S. M., Curtis S. E., Bradley W. E. Facilitation of oxygen transfer by Perflubron hemodilute dogs. Adv Exp Med Biol 1992; 317: 479–84
   PubMedGoogle Scholar
• Faithfull N. S. Mechanisms and efficacy of fluorochemical oxygen transport and delivery. Biomater Artif Cells Immobilization Biotechnol 1994; 22(2)181–97
   Google Scholar
• Cernaianu A. C., Spence R. K., Vasilidze T., et al. Transfusion Triggers with Perflubron (Oxygent™ HT) in a canine model of surgical hemodilution. Biomater Artif Cells Immobilization Biotechnol
   Google Scholar
• Wahr J. A., Trouwborst A., Spence R. K., et al. A pilot study of the efficacy of an oxygen carrying emulsion, Oxygent™ HT, in patients undergoing surgical blood loss (abstract). Anesth
   Google Scholar